<DOC>
<DOCNO>EP-0657454</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Imidazopyridazines being angiotensin II antagonists.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3150	A61K3150	A61P900	A61P900	A61P910	A61P912	A61P2500	A61P2500	A61P2700	A61P2702	A61P4300	A61P4300	C07B4300	C07B4300	C07D48700	C07D48704	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	C07B	C07B	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61P9	A61P9	A61P9	A61P9	A61P25	A61P25	A61P27	A61P27	A61P43	A61P43	C07B43	C07B43	C07D487	C07D487	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Imidazopyridazine derivatives of the formula I 
<
IMAGE
>
  in which R is 
<
IMAGE
>
 and R
<
1
>
, R
<
2
>
, R
<
3
>
, X and Y have the meanings stated in Claim 1, and the salts thereof show angiotensin II-antagonistic properties and can be used for the treatment of hypertension, aldosteronism, heart failure and elevated intraocular pressure and of central nervous system disorders.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
MERCK PATENT GMBH
</APPLICANT-NAME>
<APPLICANT-NAME>
MERCK PATENT GMBH
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
BEIER DR NORBERT
</INVENTOR-NAME>
<INVENTOR-NAME>
DORSCH DR DIETER
</INVENTOR-NAME>
<INVENTOR-NAME>
LUES DR INGEBORG
</INVENTOR-NAME>
<INVENTOR-NAME>
MEDERSKI DR WERNER
</INVENTOR-NAME>
<INVENTOR-NAME>
MINCK DR KLAUS-OTTO
</INVENTOR-NAME>
<INVENTOR-NAME>
OSSWALD DR MATHIAS
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHELLING PROF DR PIERRE
</INVENTOR-NAME>
<INVENTOR-NAME>
BEIER, DR. NORBERT
</INVENTOR-NAME>
<INVENTOR-NAME>
DORSCH, DR. DIETER
</INVENTOR-NAME>
<INVENTOR-NAME>
LUES, DR. INGEBORG
</INVENTOR-NAME>
<INVENTOR-NAME>
MEDERSKI, DR. WERNER
</INVENTOR-NAME>
<INVENTOR-NAME>
MINCK, DR. KLAUS-OTTO
</INVENTOR-NAME>
<INVENTOR-NAME>
OSSWALD, DR. MATHIAS
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHELLING, PROF. DR. PIERRE
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
